Moving Medicine Forward

The Future is Cellular: Optieum Bio’s Next-Generation Approach to Glioblastoma

Glioblastoma remains one of the most aggressive and difficult-to-treat forms of brain cancer, with recurrence posing a significant challenge for patients and researchers

One Mission, Many Journeys: Celebrating 27 Years of CTI

As CTI celebrates 27 years of moving medicine forward, Hadley Decker, Senior Director, Global Training and Development, and Natiq Fazlani, Research Associate, share their

More Time, More Options, More Hope: The Alzheimer's Association's Roadmap for Early Screening

Alzheimer's disease affects millions of individuals and families, yet many people remain unaware of the critical role early detection can play in improving outcomes. In t

Funding the Future: Closing Critical Gaps in Childhood Cancer Research

Childhood cancer research faces unique challenges, from limited funding opportunities to fewer treatment options compared to adult cancers. In this episode of Moving Medi

MMF Rewind | Building Better Clinical Trials: Study Start-Up, Patients, and Global Data

This week, we're revisiting a previous conversation with Megan Kamm, Senior Vice President of Client Delivery, and Josh Schroeder, Vice President of Site & Field Operatio

Stronger Together: Families, Researchers, and CancerFree KIDS

Childhood cancer research advances through the combined efforts of families, researchers, advocates, and donors. In this episode, Matt Robinson of CancerFree KIDS and Dr.

New Path, Same Purpose: Dedicated to Advancing Transplant Research

After nearly 40 years caring for transplant patients and more than 25 years in clinical research, Dr. Helio Tedesco has made a unique transition from investigator to CRO

Chill, Not Kill: How Quell Therapeutics is Reimagining Cell Therapy

In this episode of Moving Medicine Forward, Jeremy Schrand is joined by Luke Devey, Chief Medical Officer at Quell Therapeutics, and Savannah Doliboa, Chief Commercial Of

Beyond the Fine Print: How Legal Affairs Enables Clinical Research

Ian Hennessey, Vice President & General Counsel at CTI, joins Moving Medicine Forward to discuss the critical role legal affairs plays in advancing global clinical resear

Inside Pharmacovigilance: Detecting Risks, Protecting Patients

What happens behind the scenes to ensure new therapies are safe for patients? In this episode of Moving Medicine Forward, we are joined by John Kane, Vice President of Ph

Building Better Clinical Trials: Study Start-Up, Patients, and Global Data

What does it take to set a complex global clinical trial up for success? In this episode of Moving Medicine Forward, we are joined by Megan Kamm, Senior Vice President of

From Australia to China: CTI's APAC Growth Journey

Asia Pacific has become one of the fastest-growing regions in clinical research, offering sponsors new opportunities to advance clinical development in an increasingly co

ALK Positive: How Patients are Driving Research

Summer Farmen and Jeff Sturm share their personal cancer journeys and the mission behind ALK Positive, CTI’s Q3 Charity of the Quarter. ALK Positive is a patient-driven

MMF Rewind | CTI's Next Chapter: A Conversation with Jon Koch and Brian Lawrence

This week, we're revisiting a previous conversation with Jon Koch, CEO, and Brian Lawrence, CFO and President, as they share their perspective on what’s next for CTI as t

Small Wins, Big Impact: Lessons from Pediatric Oncology

What does it take to design clinical trials that truly put patients first—especially when those patients are children? In this episode of Moving Medicine Forward, Dr. Ra

Biorepositories in Action: Protecting the Integrity of Every Sample

In this episode, we’re joined by Rafael Miñana Prieto, Senior Manager of Operations for Laboratory Services at CTI, who oversees global biorepository operations across th

Engineering Organs: The Science Powering Xenotransplantation

In this episode of Moving Medicine Forward, Dr. Robert Fisher—one of the pioneers of modern transplant surgery—explores the rapidly advancing field of xenotransplantation

Adapting to Industry Rebound: The Next Phase of Clinical Trials

What does a recovering clinical research market actually look like in 2026? In this episode, Joel White, Owner of Market Cap Consulting, and Ryan Gifford, Vice President

MMF Rewind | Life After Transplant, Reimagined: Enduring Hearts & Pediatric Research

In this MMF Rewind, we’re bringing back an important conversation with Lynda Lee Smith—one that shines a light on the ongoing challenges transplant families face and the

CTI’s Next Chapter: A Conversation with Jon Koch and Brian Lawrence

In this episode, Jon Koch, CEO, and Brian Lawrence, CFO and President, share their perspective on what’s next for CTI as the organization enters a new phase of growth. Th